logo
  

Bayer Proposes Former CEO Wenning As Chairman, To Hike Dividend By 10%

German conglomerate Bayer AG (BAYRY.PK,BAYZF.PK) on Thursday proposed to elect its former Chief Executive Officer Werner Wenning as Chairman of its Supervisory Board with effect from October 1. He will succeed Manfred Schneider, who will remain in office until September 30.

Separately, the health care, nutrition and high-tech materials holding company said its Supervisory Board approved the recommendation of a 10 percent increase in annual dividend. The company will propose for the management changes as well as dividend in its Annual Stockholders' Meeting on April 27.

Wenning, 65, was the Chief Executive Officer from April 2002 until September 30, 2010. He will be the Chairman for the term until 2017. The company noted that the statutory "cooling-off period", after which former members of a company's board of management may join its supervisory board, ends after two years.

The Chairman is not directly elected by the Annual Stockholders' Meeting but by the members of the Supervisory Board.

In addition, the company also nominated two candidates for election as new stockholder representatives, including Sue Rataj, a board member of U.S. chemicals company Cabot Corp., and Thomas Ebeling, Chief Executive Officer of Germany's ProSiebenSat.1 Media AG.

The company added that it will also ask in the Stockholders' Meeting to vote on the introduction of a new compensation system for the Supervisory Board members. As per the new system, each member receive only fixed annual compensation of 120 thousand euros plus additional compensation for committee membership. The Chairman of the Supervisory Board would receive fixed compensation of 360 thousand euros annually.

Regarding its dividend proposal, the company said it plans to pay a dividend of 1.65 euros per share, higher than last year's 1.50 euros.

CEO Marijn Dekkers commented that "2011 was a very successful year for Bayer, and we want our stockholders to appropriately benefit from the company's performance."

On Frankfurt's Xetra, Bayer shares closed Thursday's trading at $56.02, down $0.05 or 0.09 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23. Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
Follow RTT